JADPRO Live 2017 Activities
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
Narratives: HER2-Positive Breast Cancer
New Drug Updates in Solid Tumors: PARP Inhibitors in Ovarian Cancer, Immunotherapeutics, and Other Agents
What are the signs and symptoms of serious adverse effects linked with newly approved solid tumor drugs?
Edward Li, PharmD, MPH, BCOP
Edward Li, PharmD, MPH, BCOP, on solid tumors: new drug approvals.
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.